Puvvala Yugandhar - Aurobindo Pharma CEO Specialities

AUROPHARMA   1,224  6.70  0.55%   

CEO

Puvvala Yugandhar is CEO Specialities of Aurobindo Pharma Limited
Phone91 40 6672 5000
Webhttps://www.aurobindo.com

Aurobindo Pharma Management Efficiency

The company has return on total asset (ROA) of 0.0677 % which means that it generated a profit of $0.0677 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1213 %, meaning that it generated $0.1213 on every $100 dollars invested by stockholders. Aurobindo Pharma's management efficiency ratios could be used to measure how well Aurobindo Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Aurobindo Pharma Limited has accumulated 66.48 B in total debt. Debt can assist Aurobindo Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Aurobindo Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aurobindo Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aurobindo to invest in growth at high rates of return. When we think about Aurobindo Pharma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CEO Age

Sanjay SethiChalet Hotels Limited
59
Aurobindo Pharma Limited (AUROPHARMA) is traded on National Stock Exchange of India in India and employs 26,015 people. Aurobindo Pharma is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Aurobindo Pharma Leadership Team

Elected by the shareholders, the Aurobindo Pharma's board of directors comprises two types of representatives: Aurobindo Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurobindo. The board's role is to monitor Aurobindo Pharma's management team and ensure that shareholders' interests are well served. Aurobindo Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurobindo Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rama Rao, President QA
Venugopalan Muralidharan, President Business
Ravikiran, Chief Officer
G Prasad, Senior Operations
Penaka Reddy, WholeTime Director
Vijaya Kumar, President Technical
Sanjay MSc, Chief Limited
Meenakshi Sivakumaran, WholeTime Director
Damodharan, Chief vertical
Kambam Reddy, Vice MD
Swami Iyer, Chief America
Sudhir Singhi, Head Operations
BE MBA, CEO Biologics
Mettu Reddy, WholeTime Director
Arvind Bothra, Head Communications
Sanjeev Dani, COO Formulations
Puvvala Yugandhar, CEO Specialities
Shriniwas Dange, Investor Executive
Adi Reddy, Compliance Secretary
Santhanam Subramanian, Chief Officer
V Handa, President Research

Aurobindo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aurobindo Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Aurobindo Stock

Aurobindo Pharma financial ratios help investors to determine whether Aurobindo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurobindo with respect to the benefits of owning Aurobindo Pharma security.